Literature DB >> 1591229

Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes.

H Sarlund1, K Pyörälä, I Penttilä, M Laakso.   

Abstract

Coronary heart disease risk factor levels were studied in 184 first-degree relatives (sisters and brothers) of non-insulin-dependent diabetic subjects (124 relatives with normoglycemia, 34 relatives with impaired glucose tolerance [IGT], and 26 relatives with non-insulin-dependent diabetes mellitus [NIDDM]) and in 215 relatives of nondiabetic subjects (194 relatives with normoglycemia and 21 relatives with IGT). Subjects with IGT exhibited the highest insulin responses to an oral glucose load. Systolic blood pressure was significantly higher; serum high density lipoprotein cholesterol level was significantly lower; and total, low density lipoprotein, and very low density lipoprotein triglyceride levels were higher in the relatives with a family history of diabetes who had IGT or NIDDM than in the normoglycemic relatives without a family history of diabetes. These abnormal changes were not seen in normoglycemic relatives or relatives with IGT who had no family history of NIDDM. Thus, in relatives of diabetics, abnormal glucose tolerance seems to induce changes in cardiovascular heart disease risk factor levels that are similar to those observed in NIDDM. Therefore, a family history of diabetes adds substantially to the risk for atherosclerosis, particularly in subjects with IGT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591229     DOI: 10.1161/01.atv.12.6.657

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  6 in total

1.  New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland.

Authors:  J Rissanen; J Pihlajamäki; S Heikkinen; P Kekäläinen; L Mykkänen; J Kuusisto; A Kolle; M Laakso
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

2.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

3.  Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.

Authors:  M Laakso; M Malkki; P Kekäläinen; J Kuusisto; S S Deeb
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

4.  Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine.

Authors:  O Stephen Ogedengbe; Ignatius U Ezeani; Ijezie I Chukwuonye; Ernest N Anyabolu; Ikemefuna I Ozor; Aihanuwa Eregie
Journal:  Diabetes Metab Syndr Obes       Date:  2015-09-18       Impact factor: 3.168

5.  Comparison of the effects of sibling and parental history of type 2 diabetes on metabolic syndrome.

Authors:  Hsuan Chiu; Mei-Yueh Lee; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen; Jer-Ming Chang
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

Review 6.  Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?

Authors:  Tuomo Rankinen; Mark A Sarzynski; Sujoy Ghosh; Claude Bouchard
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.